SYRE
Spyre Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SYRE Filings
Filing Date
Form Description
Form Type
2025-12-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-05
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-05 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-04
Form 8-K - Current report
Key Events
2025-11-04 · Key Events
Form 8-K - Current report
2025-11-04
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-04 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-03
Form 144 - Report of proposed sale of securities
Ownership
2025-11-03 · Ownership
Form 144 - Report of proposed sale of securities
2025-10-17
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-10-17 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-10-15
Form 8-K - Current report
Key Events
2025-10-15 · Key Events
Form 8-K - Current report
2025-10-14
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-14 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-14
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-14 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-14
Form 8-K - Current report
Key Events
2025-10-14 · Key Events
Form 8-K - Current report
